Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "avian influenza" return 10 results.
Signature of a scientific collaboration protocol about avian influenza with South China Agricultural University >
Ceva, a socially responsible company committed to the well-being of the planet
Monitoring the intake of a gumboro immune-complex vaccine administered in the hatchery. >
Its use and examples compared to the classical vaccination method.
Ceva conducts Global Vector Vaccine Symposium >
Ceva, a global leader in vector vaccines technology, hosted over 280 participants from 41 countries at its first Vector Vaccine Symposium on October 06-08, 2010.
Frequently asked questions - Vectormune® >
Vectormune ® FP-MG What is the interest level for the newest Vectormune ® FP-MG vaccine? Questions and Answers about MG What is the average percent of incidence of MG in the layer complexes acro...
Vaccines >
Infectious Bursal Disease (IBD) has been a long standing challenge in the field. Producers needed a vaccine that worked in the presence of a relatively high level of maternal antibodies.
Poultry >
Poultry vaccine technology is one of our company’s core specialties.
Vectormune FP-MG >
What is the interest level for the newest Vectormune FP-MG vaccine?
Contributions >
Ceva is making a huge contribution in the global fight against animal diseases.
Support programmes >
An alliance between Ceva, the international community, civil society and researchers are making a significant difference to the lives of poor people.
Company overview >
Ceva Animal Health (Pty) Ltd is a subsidiary of Ceva Santé Animale, an international company with its principal offices in Libourne, France.